Strata Critical Medical (SRTA) Current Assets (2019 - 2026)

Strata Critical Medical (SRTA) has 8 years of Current Assets data on file, last reported at $124.1 million in Q1 2026.

• Quarterly Current Assets fell 18.49% year-over-year to $124.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $124.1 million (down 18.49% YoY) and the FY2025 annual result came in at $126.2 million, down 21.49% from the prior year.
• Current Assets eased to $124.1 million in Q1 2026 per SRTA's latest filing, from $126.2 million in the prior quarter.
• Across five years, Current Assets topped out at $285.3 million in Q1 2022 and bottomed at $122.5 million in Q3 2025.
• The 5-year median for Current Assets is $194.0 million (2024), against an average of $190.1 million.
• The widest annual swing landed in 2022, when Current Assets surged 46761.94%; it then declined 28.69% in 2025.
• Tracing SRTA's Current Assets over 5 years: stood at $218.1 million in 2022, then retreated by 5.44% to $206.3 million in 2023, then retreated by 22.07% to $160.7 million in 2024, then fell by 21.49% to $126.2 million in 2025, then slipped by 1.62% to $124.1 million in 2026.
• Per Business Quant, the three latest SRTA Current Assets figures stand at $124.1 million (Q1 2026), $126.2 million (Q4 2025), and $122.5 million (Q3 2025).

Peer Comparison